CN102526622B - Medicine for treating knee-joint bursitis - Google Patents
Medicine for treating knee-joint bursitis Download PDFInfo
- Publication number
- CN102526622B CN102526622B CN 201210022618 CN201210022618A CN102526622B CN 102526622 B CN102526622 B CN 102526622B CN 201210022618 CN201210022618 CN 201210022618 CN 201210022618 A CN201210022618 A CN 201210022618A CN 102526622 B CN102526622 B CN 102526622B
- Authority
- CN
- China
- Prior art keywords
- grams
- medicine
- bursitis
- radix
- bag
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating knee-joint bursitis, which is prepared by the following components in mass by weight: 12g of achyranthes bidentata, 12g of cassia twig, 12g of rhizoma atractylodis, 16g of ginkgo leaf, 12g of red flower, 18g of radix curcumae, 15g of radix paeoniae rubra, 10g of panax pseudoginseng, 15g of waxgourd peel and 15g of agaric. All the components are mixed uniformly, are crushed into fine powder with 150 meshes, and subpackaged into bags, and the medicine powder in each bag is 6g. The medicine is taken after meal with one bag for one day, and is takenwith water by twice.
Description
Technical field the invention belongs to technical field of Chinese medicines, relates to a kind of medicine for the treatment of the knee joint bursitis, is the Chinese patent medicine of feedstock production specifically with the Chinese herbal medicine.
The background technology synovial bursa is to be positioned at the frequent or bigger buffer structure of pressure of human body friction, and its skin is fibrous connective tissue, and internal layer is synovial membrane, and a small amount of synovial fluid is arranged in the capsule at ordinary times.Because joint surrounding structure complexity, movable frequent, old friend's body synovial bursa is present in big juxtra-articular more.The formation of bursitis be because long-term, continue, repeatedly, concentrate and friction that strength is big slightly and compressing be produce bursitis main cause, pathological change is synovial membrane edema, hyperemia, thicken and be the fine hair shape, synovial fluid increases, cyst wall fibrosis etc., synovial membrane is if little angiorrhexis, it is courageous and upright that synovial fluid can be, because knee joint heavy burden activity is more, this disease is sent out at this position well.Western medical treatment should disease inject hormone (as predniso lone acetate) after extracting the capsule content out at present, but should disease recur easily under the situation that the cause of disease is not eliminated, and influenced patient's work and life.Motherland's medical science thinks that this disease is outer injure cold-damp invasion and attack, blood stasis edema and cause arthroncus, the warming the interior damp eliminating of Chinese medicine, inducing diuresis to remove edema, blood circulation promoting and blood stasis dispelling tool great potential aspect this disease for the treatment of, therefore inventing a kind of medicine for the treatment of the knee joint bursitis treats this disease.
Summary of the invention the purpose of this invention is to provide a kind of medicine for the treatment of the knee joint bursitis, to overcome the deficiencies in the prior art.
The objective of the invention is according to pathogenetic understanding and the Therapeutic Principle thereof of motherland's medical tradition medical science to the knee joint bursitis, with reference to modern pharmacological research, therefrom filter out the natural Chinese medicinal herb of warming the interior damp eliminating, inducing diuresis to remove edema, blood circulation promoting and blood stasis dispelling, by the theory of Chinese medical science prescription, it is played a role.
Medicine of the present invention is made by following component:
Radix Achyranthis Bidentatae 12 gram Ramulus Cinnamomi 12 gram Rhizoma Atractylodis 12 gram Folium Ginkgos 16 gram Flos Carthamis 12 gram Radix Curcumaes 18 gram Radix Paeoniae Rubra 15 gram Radix Notoginseng 10 gram Exocarpium Benincasaes 15 gram Polyporus 15 grams
Above-mentioned each component mix homogeneously is ground into 150 order fine powders, is distributed into bag, every packed medicated powder 6 grams.One after each meal, is used mixing in water for oral taking at twice at one bag of every day.
Medicine of the present invention is Chinese medicine preparation, and is theoretical according to traditional Chinese medical science prescription, select medicine rationally, warming the interior damp eliminating, inducing diuresis to remove edema, blood circulation promoting and blood stasis dispelling, treating both the principal and secondary aspects of a disease.Medicine of the present invention, through clinical observation patient for many years, evident in efficacy, the knee joint bursitis patient that a variety of causes is caused has remarkable result.
Clinical drug of the present invention is taken the result and is shown, following advantage is arranged:
It is raw material that the present invention selects natural plant for use, and each component meets the pharmaceutical control law regulation, utilizes the comprehensive function treatment knee joint bursitis of the medicine of respectively distinguishing the flavor of, and no chemicals is nontoxic to human body, has no side effect, and is safe and reliable.The present invention is powder, and effective ingredient scatters and disappears few, and the curative effect height is cheap, taking convenience, no any discomfort disease.
For showing that medicine of the present invention is to the therapeutic effect of knee joint bursitis, the present invention is through the clinical observation of 88 routine knee joint bursitis patient systems, and select medical history, the state of an illness, age and knee joint bursitis patient 86 examples suitable with traditional therapy to organize as a comparison, age 16-62 year, course of disease 1-6; Test group: take medicine of the present invention; Matched group: use routine medication.Observation period is 3 months, checks after half a year.Efficacy assessment standard adopts in People's Republic of China's Chinese medicine industry standard in 2005 " disease of tcm diagnosis criterion of therapeutical effect ".Cure: swelling pain disappears, and the knee joint activity is normal, and the no pain of squatting down walks rapidly.The good effect: swelling pain obviously alleviates, the overworked mild pain that still has, and knee joint function is normal.Take a turn for the better: swelling pain alleviates, the overworked pain that still has, and knee joint function is normal substantially.Do not heal: swelling shows effect repeatedly, and the gonalgia is not alleviated.
Instructions of taking: every packed medicated powder 6 grams.One after each meal, is used mixing in water for oral taking at twice at one bag of every day.Clinical comparison the results are shown in Table 1.
Table 1: take medicine of the present invention with the observation of curative effect of conventional treatments to knee joint bursitis patient.
Two groups of curative effects comparisons of table 1 (example, %)
| Group | n | Cure | The good effect | Effectively | Do not heal | Total significant figure |
| Experimental group | 88 | 58(65.9) | 20(22.7) | 8(9.1) | 2(2.3) | 86(97.7) |
| Matched group | 86 | 38(44.2) | 18(20.9) | 14(16.3) | 16(18.6) | 70(81.4) |
Annotate: curative effect relatively adopts statistical method, and enumeration data adopts X
2Check, two groups of effective percentage compare P＜0.01
As can be seen from Table 1, medicine of the present invention is obtained 58 examples that have of significant curative effect to 88 routine knee joint bursitis patients, accounts for 69.5%, and 20 examples that have of good result are arranged, and accounts for 22.7%, and 8 examples are effectively arranged, and accounts for 9.1%; Total effective rate reaches 97.7%.(experimental group and matched group effective percentage be P＜0.01 relatively) illustrates that medicine of the present invention has the significance curative effect.
The specific embodiment
Choose raw material by following proportioning:
Radix Achyranthis Bidentatae 12 gram Ramulus Cinnamomi 12 gram Rhizoma Atractylodis 12 gram Folium Ginkgos 16 gram Flos Carthamis 12 gram Radix Curcumaes 18 gram Radix Paeoniae Rubra 15 gram Radix Notoginseng 10 gram Exocarpium Benincasaes 15 gram Polyporus 15 grams; Above-mentioned each component mix homogeneously is ground into 150 order fine powders, is distributed into bag, every packed medicated powder 6 grams.One after each meal, is used mixing in water for oral taking at twice at one bag of every day.
Claims (1)
1. a medicine for the treatment of the knee joint bursitis is the powder of being made by the following weight proportion raw material: Radix Achyranthis Bidentatae 12 grams, Ramulus Cinnamomi 12 grams, Rhizoma Atractylodis 12 grams, Folium Ginkgo 16 grams, Flos Carthami 12 grams, Radix Curcumae 18 grams, Radix Paeoniae Rubra 15 grams, Radix Notoginseng 10 grams, Exocarpium Benincasae 15 grams, Polyporus 15 grams; Above-mentioned each component mix homogeneously is ground into 150 order fine powders, is distributed into bag, every packed medicated powder 6 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210022618 CN102526622B (en) | 2012-01-05 | 2012-01-05 | Medicine for treating knee-joint bursitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210022618 CN102526622B (en) | 2012-01-05 | 2012-01-05 | Medicine for treating knee-joint bursitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102526622A CN102526622A (en) | 2012-07-04 |
| CN102526622B true CN102526622B (en) | 2013-10-02 |
Family
ID=46335442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210022618 Expired - Fee Related CN102526622B (en) | 2012-01-05 | 2012-01-05 | Medicine for treating knee-joint bursitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102526622B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104784580A (en) * | 2015-05-19 | 2015-07-22 | 黄芳 | Traditional Chinese medicine composition and acupuncture point acupuncture and moxibustion combined application for treating knee-joint pain |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101757502A (en) * | 2008-10-22 | 2010-06-30 | 宋修芳 | Medicament for treating traumatic joint periostitis and bursitis |
-
2012
- 2012-01-05 CN CN 201210022618 patent/CN102526622B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102526622A (en) | 2012-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101693102A (en) | Traditional Chinese medicine compound for treating diseases of incoordination between the spleen and the stomach and abdominal fullness and distention and preparation method thereof | |
| CN103007216A (en) | Chinese medicinal composition for treating chronic diarrhea | |
| CN105079757A (en) | Traditional Chinese medicine composition for treating emphysema | |
| CN101954042A (en) | Tumor eliminating capsule | |
| CN101912567B (en) | Chinese medicinal prescription for treating chronic myocarditis | |
| CN103721082B (en) | A kind of Chinese medicine composition of cure scapulohumeral periarthritis | |
| CN102526622B (en) | Medicine for treating knee-joint bursitis | |
| CN101491612B (en) | Medicine for treating mammary hyperplasia and early breast cancer | |
| CN103705846A (en) | Traditional Chinese medicine preparation for treating ovarian cyst | |
| CN103405602A (en) | Medicament for treating asthma | |
| CN103007237B (en) | Medicine for treating idiopathic thrombocytopenic purpura (ITP) | |
| CN101757396B (en) | Traditional Chinese medicine composition for treating deficiency of kidney qi and impotence and spermatorrhea and preparation method thereof | |
| CN103070992B (en) | Medicine for treating high myopia macular hemorrhages | |
| CN103157011B (en) | Traditional Chinese medicine composite for promoting fracture healing | |
| CN103212013A (en) | Chinese medicinal composition for treating epigastric pain | |
| CN102552570B (en) | Medicine for treating acra necrosis after bone trauma | |
| CN1994412A (en) | Medicinal capsule for treating cestodiasis | |
| CN101502597A (en) | Medicament for treating stomachache and preparation method thereof | |
| CN103655875B (en) | Treatment blood sampling causes the medicine of Patients with Aplastic Anemia venous thrombosis | |
| CN102512637B (en) | Medicine for treating special chronic sinusitis of patients | |
| CN104758539A (en) | Traditional Chinese medicine composition for treating debilitation | |
| CN104906385A (en) | Traditional Chinese medicine composition for treating diarrhoea | |
| CN102657813A (en) | Medicament for treating chronic leg ulcers | |
| CN103263516B (en) | Medicine for treating cholecystitis | |
| CN103301261A (en) | Medicine for treating transplant kidney main renal venous stenosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131002 Termination date: 20140105 |